Ruan Yingding, Cao Wenjun, Han Jianwei, Yang Aiming, Xu Jincheng, Zhang Ting
Department of Thoracic Surgery, The First People's Hospital of Jiande, Jiande, China.
Department of Thoracic Surgery, Affiliated Zhongshan Hospital of Dalian University, Dalian, China.
Front Oncol. 2025 Mar 18;15:1489068. doi: 10.3389/fonc.2025.1489068. eCollection 2025.
This study examined the effectiveness of preoperative inflammatory markers in predicting the occurrence of postoperative pneumonia (POP) and clinical outcomes based on chest computed tomography (CT) images in patients who underwent surgical resection for non-small cell lung cancer (NSCLC).
This retrospective study included NSCLC patients who underwent lung cancer surgery at The First People's Hospital of Jiande between January 2019 and October 2023. Data on demographic characteristics, preoperative inflammatory biomarkers, surgical approach and duration, postoperative outcomes, and CT findings 1 month postoperatively were collected and analyzed. The effectiveness of preoperative inflammatory markers in predicting POP and clinical outcomes 1 month after surgical resection was assessed using propensity score matching.
Among 568 patients, 72 (12.7%) had POP. After matching, 252 patients (POP group: 66; non-POP group: 186) were included in the analysis. The systemic immune-inflammation index (SII) and platelet-to-lymphocyte ratio (PLR) were significantly higher in the POP group than in the non-POP group (433.53 vs. 323.75, = 0.001; 126.42 vs. 103.64, < 0.001). The length of hospital stay and the percentage of patients who improved clinically based on chest CT findings 1 month after surgery were significantly higher in the POP group than in the non-POP group (11 days vs. 9 days, = 0.008; 77.3% vs. 59.7%, = 0.033). Multivariate analysis showed that PLR and the lymphocyte-to-monocyte ratio (LMR) were independent predictors of POP (AUC of 0.780 and 0.730, both at < 0.001). However, there were no significant differences in postoperative radiographic outcomes among patients stratified by risk of POP.
PLR and LMR accurately predict POP in surgical patients with NSCLC. Nonetheless, these ratios may not significantly predict radiographic outcomes 1 month after surgical resection.
本研究基于胸部计算机断层扫描(CT)图像,探讨术前炎症标志物对接受非小细胞肺癌(NSCLC)手术切除患者术后肺炎(POP)发生情况及临床结局的预测效果。
本回顾性研究纳入了2019年1月至2023年10月期间在建德市第一人民医院接受肺癌手术的NSCLC患者。收集并分析了患者的人口统计学特征、术前炎症生物标志物、手术方式及时长、术后结局以及术后1个月的CT检查结果。采用倾向得分匹配法评估术前炎症标志物对手术切除后1个月时POP及临床结局的预测效果。
568例患者中,72例(12.7%)发生POP。匹配后,252例患者(POP组:66例;非POP组:186例)纳入分析。POP组的全身免疫炎症指数(SII)和血小板与淋巴细胞比值(PLR)显著高于非POP组(433.53对323.75,P = 0.001;126.42对